BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29108386)

  • 1. Single nucleotide polymorphisms in
    Zhu X; Liu W; Qiu X; Wang Z; Tan C; Bei C; Qin L; Ren Y; Tan S
    Oncotarget; 2017 Oct; 8(45):80039-80049. PubMed ID: 29108386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.
    Zhu X; Wang Z; Qiu X; Tan C; Yu H; Bei C; Qin L; Ren Y; Tan S
    Carcinogenesis; 2017 May; 38(5):532-540. PubMed ID: 28369212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer.
    Wang D; Zhang X; Zhang Y; Wu Y; Guan X; Zhu W; Wang M; Qi C; Shen B
    Onco Targets Ther; 2018; 11():8083-8088. PubMed ID: 30519050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
    Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
    Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
    Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
    Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis.
    Chen H; Shen Z; Hu Y; Xiao Q; Bei D; Shen X; Ding K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2147-58. PubMed ID: 25986311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
    Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
    Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.
    Tang W; Liu X; Qiu L; Zhao X; Huang M; Yin J; Li J; Guo W; Zhu X; Chen Z
    Oncol Lett; 2018 Jan; 15(1):1334-1342. PubMed ID: 29399184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
    Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
    Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.
    Chen W; Zhou C; Zhang W; Atyah M; Yin Y; Guo L; Tang W; Dong Q; Ye Q; Ren N
    J Cancer; 2018; 9(7):1239-1247. PubMed ID: 29675105
    [No Abstract]   [Full Text] [Related]  

  • 16. MLH1 rs1800734 Pathogenic Variant among Patients with Colorectal Cancer in the Lower Northeastern Region of Thailand.
    Pongsavee M; Wisuwan K; Pongsavee K
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2911-2916. PubMed ID: 37642081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
    Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
    Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.
    Lin LH; Lin MW; Mar K; Lin CS; Ji DD; Lee WP; Lee HS; Cheng MF; Hsia KT
    Ann Surg Oncol; 2014 Dec; 21(13):4270-7. PubMed ID: 25047469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.